Indications
Ridicef is indicated for the treatment of Community Acquired Pneumonia, Acute Exacerbations of Chronic Bronchitis, Acute Maxillary Sinusitis, Pharyngitis/Tonsillitis, Acute Bacterial Otitis Media, and Uncomplicated Skin and Skin Structure Infections.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Cefdinir is a semisynthetic third generation oral cephalosporin antibiotic. It kills bacteria over a broad range, working against many of the common pathogens that cause infection, including beta-lactamase producing strains such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Moraxella catarrhalis, E. coli, Klebsiella pneumoniae and Proteus mirabilis. Like other cephalosporins, Cefexta kills bacteria by stopping them from building their cell walls.
Pregnancy & Breastfeeding
Its pregnancy category is B, though there are no adequate, well-controlled studies in pregnant women, so Cefdinir should be used in pregnancy only when clearly needed. In studies where a single 600 mg dose was given, it was not detected in breast milk.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.